Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Total revenue	$ 8,615	$ 6,712	$ 16,804	$ 12,321
Operating expenses:
Cost of sales	1,495	1,108	2,122	1,662
Research and development	77,401	68,895	146,021	136,196
Selling, general and administrative	35,536	30,409	66,550	58,776
Total operating expenses	114,432	100,412	214,693	196,634
Loss from operations	(105,817)	(93,700)	(197,889)	(184,313)
Interest income, net	8,120	8,254	17,009	16,345
Other income, net	1,579	1,640	3,213	3,144
Net loss	$ (96,118)	$ (83,806)	$ (177,667)	$ (164,824)
Net loss per share - basic (in usd per share)	$ (1.69)	$ (1.51)	$ (3.14)	$ (2.97)
Net loss per share - diluted (in usd per share)	$ (1.69)	$ (1.51)	$ (3.14)	$ (2.97)
Weighted-average number of common shares used in computing net loss per share - basic (in shares)	56,802,546	55,604,330	56,593,011	55,435,796
Weighted-average number of common shares used in computing net loss per share – diluted (in shares)	56,802,546	55,604,330	56,593,011	55,435,796
Product revenue, net
Revenues:
Total revenue	$ 8,615	$ 6,712	$ 16,804	$ 12,321